Authors
Loading...
This research shows improved DNA-binding properties in engineered transcription factors, highlighting their potential as bioactive modulators.
Harel et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: